Optimal post-remission therapy for flow-cytometry minimal residual disease positive patients with acute myeloid leukemia

被引：0
|
作者：
Venditti, A. [1 ]
Buccisano, F. [1 ]
Maurillo, L. [1 ]
Del Principe, M. I. [1 ]
Del Poeta, G. [1 ]
Ottaviani, L. [1 ]
Sarlo, C. [1 ]
Ammatuna, E. [1 ]
Fraboni, D. [1 ]
Imo-Consalvo, M. [1 ]
Amadori, S. [1 ]
机构：
[1] Univ Roma Tor Vergata, Rome, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0486
引用
收藏
页码：180 / 180
页数：1
相关论文
共 50 条
  • [1] Optimal Post-Remission Therapy for Flow-Cytometry Minimal Residual Disease Positive Adult Patients with Acute Myeloid Leukemia
    Buccisano, Francesco
    Maurillo, Luca
    Del Poeta, Giovanni
    Gattei, Valter
    Amadori, Sergio
    Venditti, Adriano
    HAEMATOLOGICA, 2006, 91 : 157 - 157
  • [2] Optimal post-remission therapy for flow-cytometry minimal residual disease positive patients with acute myeloid leukemia.
    Buccisano, Francesco
    Maurillo, Luca
    Gattei, Valter
    Del Poeta, Giovanni
    Del Principe, Maria Ilaria
    Fraboni, Fraboni
    Panetta, Paola
    Consalvo, Maria Irno
    Campagna, Selenia
    Gianni, Laura
    Ottaviani, Licia
    Postorino, Massimiliano
    De Fabritiis, Paolo
    Arcese, William
    Lo Coco, Francesco
    Amadori, Sergio
    Venditti, Adriano
    BLOOD, 2006, 108 (11) : 184A - 184A
  • [3] Allogeneic stem cell transplantation is the optimal post-remission therapy in minimal residual disease positive patients with acute myeloid leukemia
    Gianni, L.
    Buccisano, F.
    Maurillo, L.
    Del Poeta, G.
    Del Principe, I
    Ottaviani, I
    Sarlo, C.
    Ammatuna, E.
    Campagna, S.
    Imo Consalvo, M.
    Amadori, A.
    Venditti, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 69 - 69
  • [4] Is it time to use minimal residual disease to stratify post-remission treatment for acute myeloid leukemia?
    Liu, Hongtao
    Stock, Wendy
    LEUKEMIA & LYMPHOMA, 2015, 56 (11) : 3005 - 3007
  • [5] Post-remission therapy for acute myeloid leukemia
    Schlenk, Richard F.
    HAEMATOLOGICA, 2014, 99 (11) : 1663 - 1670
  • [6] The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy
    Laane, Edward
    Derolf, Asa Rangert
    Bjorklund, Elisabet
    Mazur, Joanna
    Everaus, Hele
    Soderhall, Stefan
    Bjorkholm, Magnus
    Porwit-MacDonald, Anna
    HAEMATOLOGICA, 2006, 91 (06) : 833 - 836
  • [7] Post-remission therapy of acute myeloid leukemia in first remission
    Kim, ST
    Kim, K
    Lee, SH
    Kim, WS
    Jung, CW
    Lee, MH
    Park, K
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 59 - 59
  • [8] Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia
    Walter, Roland B.
    Appelbaum, Frederick R.
    Estey, Elihu H.
    LEUKEMIA, 2021, 35 (02) : 295 - 298
  • [9] Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia
    Yamamoto, Ryusuke
    Yokoyama, Akihiro
    Yoneda, Mie
    Ohashi, Kota
    Hosoda, Toru
    Kagoo, Toshiya
    Boku, Saigen
    Ueno, Hironori
    Yano, Takahiro
    ANNALS OF HEMATOLOGY, 2014, 93 (12) : 2081 - 2082
  • [10] Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia
    Roland B. Walter
    Frederick R. Appelbaum
    Elihu H. Estey
    Leukemia, 2021, 35 : 295 - 298
12345